Datwin, Baby Girl .
HRN: 21-39-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
AMPICILLIN 250MG (VIAL)
06/26/2022
07/03/2022
IV
100mg
Q12h
Potentially Septic Newborn
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes